Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Scott Dunseth Myers Insider Profile
4 Followers
Scott Dunseth Myers, President & CEO, Director at Cascadian Therapeutics, holds 0.00 shares in Harpoon Therapeutics (Ticker: HARP), holds 20.09K shares in Dynavax (Ticker: DVAX), holds 259.50K shares in Viridian Therapeutics (Ticker: VRDN).
Scott Dunseth Myers Cascadian Therapeutics (CASC)President & CEO, Director
Cascadian Therapeutics (CASC)
President & CEO, Director
Ranked #5,112 out of 98,624 Corporate Insiders
Profitable Transactions
3 out of 7 Profitable Transactions
Average Return
+47.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Scott Dunseth Myers holds in companies
Most Profitable Insider Trade
Stock:
Cascadian Therapeutics
(CASC)
(CASC)
Rating:Informative Buy
Date:Mar 21, 2017 - Mar 21, 2018
Return:+175.10%
The most profitable trade made by Scott Dunseth Myers
Scott Dunseth Myers's Trading History
Cascadian Therapeutics
Mar 13, 2018
―
Uninformative Sell
―
$0.00
Harpoon Therapeutics
Mar 11, 2024
―
Uninformative Sell
―
$0.00
Cartesian Therapeutics
Dec 26, 2019
Director
Uninformative Buy
57.54K
$1.70M
Amag Pharmaceuticals
―
―
―
―
Trillium Therapeutics
―
―
―
―
Dynavax
May 31, 2023
Director
Uninformative Buy
―
$225.20K
Viridian Therapeutics
Apr 12, 2023
CEO, Director
Informative Buy
101.44K
$3.34M
List of latest transactions for each holding click on a transaction to see Scott Dunseth Myers's performance on stock
You May Also Like
Scott Dunseth Myers insider profile FAQ
What is the percentage of profitable transactions made by Scott Dunseth Myers?
The percentage of profitable transactions made by Scott Dunseth Myers is 43%.
What is the average return per transaction made by Scott Dunseth Myers?
The average return per transaction made by Scott Dunseth Myers is 47.30%.
What stocks does Scott Dunseth Myers hold?
Scott Dunseth Myers holds: CASC, HARP, RNAC, AMAG, TRIL, DVAX, VRDN stocks.
What was Scott Dunseth Myers’s latest transaction?
Scott Dunseth Myers latest transaction was an Uninformative Sell of ―.
What was Scott Dunseth Myers's most profitable transaction?
Scott Dunseth Myers’s most profitable transaction was an Informative Buy of CASC stock on March 21, 2017. The return on the trade was 175.10%.
What is Scott Dunseth Myers's role in Cascadian Therapeutics?
Scott Dunseth Myers's role in Cascadian Therapeutics is President & CEO, Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.